New round of Gates grants

The Bill and Melinda Gates Foundation is taking applications for a new round of funding under its Grand Challenges Explorations grant program. The program, in its second year, aims to fund research that tackles developing world problems using innovative technologies and "unorthodox ideas." Since last fall, three rounds of grants have mainly funded research on infectious diseases, such as HIV, malaria, and tuberculosis, but this linkurl:fourth round;http://www.grandchallenges.org/Explorations/Pa

Written byBob Grant
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
The Bill and Melinda Gates Foundation is taking applications for a new round of funding under its Grand Challenges Explorations grant program. The program, in its second year, aims to fund research that tackles developing world problems using innovative technologies and "unorthodox ideas." Since last fall, three rounds of grants have mainly funded research on infectious diseases, such as HIV, malaria, and tuberculosis, but this linkurl:fourth round;http://www.grandchallenges.org/Explorations/Pages/ApplicationInstructions.aspx of funding adds a new subject area: contraception. "The goal of this topic is to solicit novel and innovative approaches to preventing unintended pregnancy," reads the Gates Foundation website. "We seek proposals that are 'off the beaten track,' daring in premise, and clearly different from the approaches currently being developed or employed. Overall, increasing contraceptive uptake will not only require increased supply in the developing world but a larger range of choices for women and men so that their specific needs can be met in an appropriate, safe, culturally sensitive and cost-effective manner." Examples of projects the foundation may consider include novel methods that work after ovulation, that interfere with sperm delivery, or that rely on immunology, among others. As before, successful applicants get $100,000 to start their projects, with the potential for an additional $1 million or more in funding if the project shows promise after one year. Applications for the new grants must be in to the foundation before November 2, and winners will be announced next May.
**__Related stories:__***linkurl:New fills for funding gaps;http://www.the-scientist.com/blog/display/55105/
[24th October 2008]*linkurl:Thousands vie for Gates grants;http://www.the-scientist.com/blog/display/54656/
[21st May 2008]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

  • From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.

    View Full Profile
Share
Illustration of a developing fetus surrounded by a clear fluid with a subtle yellow tinge, representing amniotic fluid.
January 2026

What Is the Amniotic Fluid Composed of?

The liquid world of fetal development provides a rich source of nutrition and protection tailored to meet the needs of the growing fetus.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies